Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.42424 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.37728 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.38701 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.34386 | 16 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.32153 | 15 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.41285 | 14 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.43509 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.36354 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.36075 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.37032 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.36264 | 15 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.36405 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.37567 | 15 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.36735 | 15 |